News
HOOKIPA Pharma Inc. (NASDAQ: HOOK, 'HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation ...
Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...
19h
AllAfrica on MSN10 Things to Know About Effectiveness of New HIV Injectable DrugGlobally, an estimated 4,000 adolescent girls and young women become infected with HIV each week, with sub-Saharan Africa accounting for more than 60% of these new infections, according to the World ...
South Africa will buy lenacapavir using Global Fund money. Studies show it can stop infections entirely in young women. But ...
Several of the events took place at ‘upscale restaurants’ in San Francisco, at costs of up to $163 per person, according to ...
23h
MedPage Today on MSNOnce-Monthly Oral PrEP Option Appears Safe, Tolerable in Adults at Low Risk of HIVThe investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results